Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$91.20
+0.5%
$92.80
$81.97
$139.06
$158.63B0.6311.38 million shs11.92 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$422.06
+0.8%
$447.24
$396.68
$603.88
$149.48B1.462.43 million shs2.77 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$232.81
+2.0%
$231.98
$149.04
$251.71
$560.33B0.267.30 million shs8.02 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+6.84%+4.90%-16.90%-31.42%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%-0.60%-6.93%-13.89%-24.36%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.40%+4.69%-3.23%+51.77%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$91.20
+0.5%
$92.80
$81.97
$139.06
$158.63B0.6311.38 million shs11.92 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$422.06
+0.8%
$447.24
$396.68
$603.88
$149.48B1.462.43 million shs2.77 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$232.81
+2.0%
$231.98
$149.04
$251.71
$560.33B0.267.30 million shs8.02 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+6.84%+4.90%-16.90%-31.42%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%-0.60%-6.93%-13.89%-24.36%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.40%+4.69%-3.23%+51.77%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.88
Moderate Buy$119.0930.58% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.67
Moderate Buy$573.6335.91% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.74
Moderate Buy$253.048.69% Upside

Current Analyst Ratings Breakdown

Latest JNJ, ABT, and ISRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/2/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingOverweight$580.00
6/2/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetSell$440.00 ➝ $366.00
5/27/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Set Price Target$558.00
5/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$121.00 ➝ $113.00
5/19/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingHold (C)
5/18/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetBuy$650.00 ➝ $520.00
5/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeHoldOutperform
5/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeMarket PerformOutperform$265.00
4/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Reiterated RatingBuy$131.00
4/24/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeHold (C)Hold (C-)
4/24/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy (B+)Buy (B)
(Data available from 6/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B3.58$7.00 per share13.03$30.35 per share3.00
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B14.85$9.28 per share45.49$50.52 per share8.35
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B5.95$14.12 per share16.49$33.85 per share6.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5725.5515.051.5213.90%17.62%10.01%7/16/2026 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.2551.1643.023.3728.15%15.98%14.07%7/28/2026 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6526.9118.482.2821.83%32.60%13.29%7/15/2026 (Estimated)

Latest JNJ, ABT, and ISRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/21/2026Q1 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billion
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
4/14/2026Q1 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.76%+10.39%70.59%54 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.362.30%+5.25%61.97%64 Years

Latest JNJ, ABT, and ISRG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/14/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.33%5/26/20265/26/20266/9/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.61
3.59
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.46
1.03
0.77

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021354.16 million352.04 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable

Recent News About These Companies

Johnson & Johnson (JNJ) Gets a Buy from Guggenheim
J&J, Medtronic back CereVasc’s $85M funding round
Nasdaq plunges 1,100 points over renewed rate hike concerns
Johnson & Johnson (NYSE:JNJ) Shares Up 2% - Still a Buy?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$91.20 +0.42 (+0.46%)
Closing price 06/5/2026 03:59 PM Eastern
Extended Trading
$90.86 -0.33 (-0.37%)
As of 06/5/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$422.06 +3.24 (+0.77%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$419.62 -2.44 (-0.58%)
As of 06/5/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$232.81 +4.64 (+2.03%)
Closing price 06/5/2026 03:59 PM Eastern
Extended Trading
$232.28 -0.53 (-0.23%)
As of 06/5/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.